PME

Pharmaceutical Market Europe - October 2020

The challenge of crowded digital channels, GSK’s Peter Howarth, why vaccinations are important, and the power of behaviour change

Pharmaceutical Market Europe - September 2020

COVID-19 casts a long shadow

Pharmaceutical Market Europe - July/August 2020

Celebrating the virtual Communique Awards 2020 and understanding the importance of behaviour change

Pharmaceutical Market Europe - June 2020

Pharmaceutical Market Europe - May 2020

Pharmaceutical Market Europe - April 2020

Pharmaceutical Market Europe - March 2020

Pharmaceutical Market Europe - February 2020

Pharmaceutical Market Europe - January 2020

Pharmaceutical Market Europe - December 2019

Pharmaceutical Market Europe - November 2019

Pharmaceutical Market Europe - October 2019

Pharmaceutical Market Europe - September 2019

Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but a foe.

Pharmaceutical Market Europe - July/August 2019

Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but a foe.

Pharmaceutical Market Europe - June 2019

Our cover star this month is a plucky little bronze statue called Fearless Girl. She originally took up her defiant pose outside the New York Stock Exchange, but can currently be found in London outside London’s own stock exchange.

Pharmaceutical Market Europe - May 2019

We are currently just at the beginning of the cell and gene therapy revolution, one which promises to cure previously untreatable diseases – and all with a single treatment.

Pharmaceutical Market Europe - April 2019

The long-running row between Vertex and NHS England and NICE over Orkambi has been a low point in the world of UK market access

Pharmaceutical Market Europe - March 2019

The EMA’s departure is a tragedy for the UK – but we’re heading for a bigger one

Pharmaceutical Market Europe - February 2019

The very idea of being able to edit our genes still sounds like something from science fiction, but in 2019, it is now very much a scientific reality.

Pharmaceutical Market Europe - January 2019

Just a few years into the New Year, the $74bn acquisition of Celgene by BMS has woken us all up from our post-festive slump with a bang. The merger is the fourth biggest ever, and could spark more multi-billion dollar M&A deals over the next 12 months.